Anthony Horner, M.D.




Rady Children's Specialists of San Diego

Medical Group / IPA

Rady Children's Specialists

Medical School

St. Louis University School of Medicine


University of California Los Angeles


Childrens Hospital Boston

Board Certifications





House dust bioactivities predict skin prick test reactivity for children with high risk of allergy.
Kim H, Tse K, Levin L, Bernstein D, Reponen T, LeMasters G, Lummus Z, Horner AA

Invariant NKT cells are required for airway inflammation induced by environmental antigens.
Wingender G, Rogers P, Batzer G, Lee MS, Bai D, Pei B, Khurana A, Kronenberg M, Horner AA

Regulatory T cells contribute to allergen tolerance induced by daily airway immunostimulant exposures.
Lee SM, Batzer G, Ng N, Lam D, Pattar SS, Patel ND, Horner AA

Regulation of aeroallergen immunity by the innate immune system: laboratory evidence for a new paradigm.
Horner AA

Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity.
Brydges SD, Mueller JL, McGeough MD, Pena CA, Misaghi A, Gandhi C, Putnam CD, Boyle DL, Firestein GS, Horner AA, Soroosh P, Watford WT, O'Shea JJ, Kastner DL, Hoffman HM

Allergen tolerance versus the allergic march: the hygiene hypothesis revisited.
Tse K, Horner AA

Airway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways.
Lam D, Ng N, Lee S, Batzer G, Horner AA

Update on toll-like receptor-directed therapies for human disease.
Tse K, Horner AA

Defining a role for ambient TLR ligand exposures in the genesis and prevention of allergic diseases.
Tse K, Horner AA

Using house dust extracts to understand the immunostimulatory activities of living environments.
Batzer G, Lam DP, Paulus P, Boasen J, Ng N, Horner AA

Update on toll-like receptor ligands and allergy: implications for immunotherapy.
Horner AA

Toll-like receptor ligands and atopy: a coin with at least two sides.
Horner AA

House dust extracts have both TH2 adjuvant and tolerogenic activities.
Ng N, Lam D, Paulus P, Batzer G, Horner AA

House dust extracts elicit Toll-like receptor-dependent dendritic cell responses.
Boasen J, Chisholm D, Lebet L, Akira S, Horner AA

Toll-like receptor ligands: hygiene, atopy and therapeutic implications.
Horner AA, Redecke V, Raz E

Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis.
Rhee CS, Libet L, Chisholm D, Takabayashi K, Baird S, Bigby TD, Lee CH, Horner AA, Raz E

Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications.
Datta SK, Cho HJ, Takabayashi K, Horner AA, Raz E

Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
Chisholm D, Libet L, Hayashi T, Horner AA

Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy.
Spiegelberg HL, Horner AA, Takabayashi K, Raz E

Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands.
Horner AA, Raz E

Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.
Takabayashi K, Libet L, Chisholm D, Zubeldia J, Horner AA

Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity.
Horner AA, Takabayashi K, Beck L, Sharma B, Zubeldia J, Baird S, Tuck S, Libet L, Spiegelberg HL, Liu FT, Raz E

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.